Levonorgestrel Intrauterine System (lng-ius, Mirena) in Dysfunctional Uterine Bleeding (dub)

Objectives: To determine progress of women presenting with dysfunctional uterine bleeding (i.e decrease in amount and duration of bleeding in days) due to a cause amenable to treatment. To evaluate improvement in Haemoglobin level (Hb gm%) in patients during treatment. Material and Methods: The study was conducted in the Department of Gynecology & Obstetrics, Khyber Teaching Hospital, Peshawar, from August 2005 to August 2007. Thirty-two patients with Dysfunctional Uterine Bleeding (DUB) in 30-45 years age group with Body Mass Index (BMI) of 18-30 willing to accept contraception during treatment period were included in the study. They were counseled, investigated and had Levonogestrel Intrauterine device Mirena inserted. Outcome was measured in terms of patient satisfaction, Hb improvement and decrease in blood loss. Record was kept and follow up done. Result: Fifty-nine percent of the patients who had been advised hysterectomy backed out and were satisfied with Mirena. Eighty-eight percent patients were relieved of menorrhagia and 100% improvement was seen in cases with polymenorrhagia. Fifty percent of patients had an Hb of >11gm% after 3 months of use. Conclusion: We conclude that Mirena is a safe and effective device to be offered as treatment to patients with DUB and it is an alternative to hysterectomy.